CBIO - Latest News
Crescent Biopharma, Inc. (CBIO), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $479.5M. Beta to the broader market is 1.26.
The article list below shows the most recent CBIO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent CBIO Headlines
Crescent Biopharma Announces Grants of Inducement Awards
globenewswire.com - Oct 6, 2026
WALTHAM, Mass. , Oct.
Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors
globenewswire.com - Oct 5, 2026
Phase 1/2 APOLLO global clinical trial to evaluate CR-002 in multiple solid tumor types, including non-small cell lung cancer (NSCLC) and head and nec
Crescent Biopharma Announces Grants of Inducement Awards
globenewswire.com - Sep 25, 2026
WALTHAM, Mass. , Sept.
Insider Selling: Crescent Biopharma (NASDAQ:CBIO) Insider Sells $11,098.00 in Stock
defenseworld.net - Sep 21, 2026
Crescent Biopharma, Inc. (NASDAQ: CBIO - Get Free Report) insider Barbara Bispham sold 620 shares of Crescent Biopharma stock in a transaction dated
Insider Selling: Crescent Biopharma (NASDAQ:CBIO) Insider Sells $11,151.70 in Stock
defenseworld.net - Sep 21, 2026
Crescent Biopharma, Inc. (NASDAQ: CBIO - Get Free Report) insider Ellie Im sold 623 shares of the stock in a transaction dated Wednesday, September 1
How News Affects CBIO Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CBIO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked CBIO news questions
- What is the latest CBIO news headline?
- The most recent CBIO headline (Oct 6, 2026) is "Crescent Biopharma Announces Grants of Inducement Awards". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the CBIO news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What CBIO news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual CBIO options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.